-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cocrystal Pharma, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2023.
- Cocrystal Pharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 10.2M shares, a 1.08% increase year-over-year.
- Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 9.65M shares, a 18.5% increase from 2022.
- Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 8.14M shares.
- Cocrystal Pharma, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2017 was 24.1M shares, a 2.52% increase from 2016.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)